Genscript USA incorporated:1171214 [18-010606]
Ended Awarded
- Contract number
- 75N95A18F00026
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,379
Award facts
- Contract value 100% obligated
- $7,378.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
GenScript USA Inc. received a $7,378.68 firm fixed price contract award from the National Institute of Neurological Disorders and Stroke (NINDS) on July 11, 2018, with an ultimate completion date of June 30, 2019. This award was issued as a call under a blanket purchase agreement (BPA) with no small business set-aside designation. The work will be performed at GenScript's facility in Piscataway, New Jersey, where the company provides advanced molecular biology services to federal agencies.
GenScript USA Inc. is a biotechnology company specializing in gene synthesis, gene editing, protein production, antibody development, and custom biological research materials for the life sciences and biomedical research sectors. The company maintains an established vendor relationship with multiple federal health agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and U.S. Department of Agriculture. This contract represents a continuation of GenScript's support for federal scientific research initiatives, leveraging the company's expertise in molecular biology services to support NINDS's neurological research mission.
Quick answers
Who was awarded contract 75N95A18F00026?
75N95A18F00026 was awarded to Genscript USA Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on July 11, 2018.
How much is contract 75N95A18F00026 worth?
The government has obligated $7,379 on 75N95A18F00026.
Is contract 75N95A18F00026 an order under another contract?
Yes. 75N95A18F00026 is a BPA call under HHSN263201400039B, a blanket purchase agreement.
Was contract 75N95A18F00026 competed?
The extent of competition for 75N95A18F00026 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award